Anixa Biosciences Inc (ANIX)
3.57
+0.10
(+2.88%)
USD |
NASDAQ |
Nov 05, 16:00
3.57
0.00 (0.00%)
After-Hours: 18:22
Anixa Biosciences Price: 3.57 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 3.60 | 3.641 | 3.41 | 3.47 | 36432.00 |
| Nov 01, 2024 | 3.56 | 3.71 | 3.56 | 3.66 | 56182.00 |
| Oct 31, 2024 | 3.56 | 3.670 | 3.47 | 3.50 | 24703.00 |
| Oct 30, 2024 | 3.95 | 3.99 | 3.41 | 3.59 | 157224.0 |
| Oct 29, 2024 | 3.99 | 4.095 | 3.83 | 3.95 | 217520.0 |
| Oct 28, 2024 | 3.43 | 3.985 | 3.41 | 3.97 | 551559.0 |
| Oct 25, 2024 | 3.15 | 3.297 | 3.15 | 3.25 | 79460.00 |
| Oct 24, 2024 | 3.12 | 3.20 | 3.10 | 3.15 | 52254.00 |
| Oct 23, 2024 | 3.03 | 3.16 | 2.97 | 3.16 | 66111.00 |
| Oct 22, 2024 | 3.05 | 3.090 | 2.93 | 3.03 | 63454.00 |
| Oct 21, 2024 | 3.00 | 3.08 | 2.98 | 3.06 | 74302.00 |
| Oct 18, 2024 | 3.01 | 3.10 | 2.99 | 3.01 | 42643.00 |
| Oct 17, 2024 | 3.105 | 3.105 | 2.95 | 2.99 | 41350.00 |
| Oct 16, 2024 | 3.03 | 3.08 | 2.99 | 3.06 | 45143.00 |
| Oct 15, 2024 | 3.05 | 3.081 | 2.95 | 3.03 | 67606.00 |
| Oct 14, 2024 | 3.00 | 3.168 | 2.980 | 3.05 | 19645.00 |
| Oct 11, 2024 | 3.00 | 3.06 | 2.97 | 3.01 | 40083.00 |
| Oct 10, 2024 | 3.09 | 3.113 | 3.00 | 3.01 | 28411.00 |
| Oct 09, 2024 | 3.07 | 3.14 | 3.02 | 3.06 | 60280.00 |
| Oct 08, 2024 | 3.13 | 3.190 | 3.04 | 3.08 | 35584.00 |
| Oct 07, 2024 | 3.13 | 3.20 | 3.13 | 3.13 | 23369.00 |
| Oct 04, 2024 | 3.17 | 3.17 | 3.11 | 3.15 | 28356.00 |
| Oct 03, 2024 | 3.14 | 3.256 | 3.13 | 3.15 | 21472.00 |
| Oct 02, 2024 | 3.12 | 3.241 | 3.12 | 3.16 | 27174.00 |
| Oct 01, 2024 | 3.10 | 3.19 | 3.096 | 3.15 | 42210.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.35
Minimum
Mar 27 2020
7.14
Maximum
Mar 17 2021
3.551
Average
3.425
Median
Jun 20 2023
Price Benchmarks
| Annovis Bio Inc | 8.26 |
| Akero Therapeutics Inc | 32.67 |
| ACADIA Pharmaceuticals Inc | 15.01 |
| Amicus Therapeutics Inc | 11.75 |
| Intra-Cellular Therapies Inc | 89.31 |
Price Related Metrics
| Price to Book Value | 5.277 |
| Earnings Yield | -10.92% |
| Market Cap | 114.88M |